Modeling Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells

Abstract

Research of genetic cardiovascular diseases has lacked of good disease models because rodents, which are primarily used, differ greatly from humans. The ability to derive human induced pluripotent stem cells (hiPSCs) from patients carrying inherited cardiac diseases has revolutionized research in the cardiovascular field. The aim for this chapter is to review the current hiPSC reprogramming methods and methods for differentiating human pluripotent stem cells (hPSCs) into cardiomyocytes. The chapter focuses on the published hiPSC models for hypertrophic cardiomyopathy (HCM) and discusses the challenges related to modeling this interesting disease using hiPSC technology.

Related Papers

• → A chemical platform for improved induction of human iPSCs(2009)603 cited
• → Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine(2010)194 cited
• Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine.(2010)
• → Generation of Human-Induced Pluripotent Stem Cells (hiPSCs) Using Episomal Vectors on Defined Essential 8™ Medium Conditions(2013)15 cited
• → Progress in the reprogramming of induced pluripotent stem cells with small molecules(2015)